Brief Recap and Updates on the MarketsAnalyst Actions and Comments - TDOC, AUPH, MU Dow +115.54 at 24873.66, Nasdaq -15.07 at 7481.73, S&P -2.15 at 2747.33 Stocks were mixed Thursday with the Dow up +115 while the Nasdaq -15 and S&P -2 were down. The S&P 500 is still testing its 50-day moving average. On the chart, the S&P is holding up just above the 50-day. The question remains, will the 50-day MA hold up? On Friday, traders will be receiving some macroeconomic numbers. These include; February Housing Starts and Building Permits, February Industrial Production and Capacity Utilization, the Job Openings and Labor Turnover Survey for January, and the preliminary reading of the University of Michigan Consumer Sentiment Index for March. Note: This Friday is a quadruple options expiration day. Nasdaq Composite: +8.4% YTDS&P 500: +2.8% YTDDow Jones Industrial Average: +0.6% YTDRussell 2000: +2.7% YTD Yesterday, KeyBanc reiterated its Outperform rating on Teladoc ($TDOC) and raised the price target from $41 to $50. Some of the reasons for this analysis were tracked down today. Experiencing strong growth in its emerging hospital and health system businessEmerging opportunity in Medicare Advantage, as a recent law allows MA plans to include telehealth services starting in 2020The analyst expects the company to break even on a free cash flow basis and earn positive free cash flow in 2019Teladoc's contract with Aetna Inc ($AET) is performing ahead of expectationsThe acquisition of 'Best Doctors' is proving to be very beneficial An article has been written about them recently here: Calling the Doctor at Teladoc Cantor Fitzgerald raised its price target for Aurinia Pharmaceuticals ($AUPH) to $16 and kept its Overweight rating after Q4 results. Company's estimated tax rate is set to decline from 21% from 35%The company remains on track to enroll its Phase 3 Aurora studyThe company is initiating studies to advance its pipeline indications for voclosporin Early Friday morning, Baird added to the recent pumping of Micron Technology ($MU). Baird raised its price target to $100.00 from $60.00 while maintaining an Outperform rating. Micron remained a top pick at Baird for 2018 based on strong memory trends. Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the like (thumbs up) button. Feel free to leave any comments and follow us.